Podcasts from The Cochrane Library
Cochrane is producing a series of reviews relevant to the COVID-19 pandemic. In July 2021, we published the first version of our review on the effects of ivermectin for the prevention and treatment of COVID-19, in a collaboration between Cochrane's Infectious Diseases and Haematological Malignancy Groups. We asked one of the authors, Maria Popp from University Hospital Wuerzburg in Germany, to tell us about their findings.
The Cochrane Common Mental Disorders Group has produced many reviews of the effects on interventions for conditions such as anxiety and depression. They added to these in November 2020 with a substantially revised version of their review of the use of cognitive behavioural therapy for children and adolescents. We asked one of the authors, Tessa Reardon from the University of Oxford in the UK, to tell us about the importance of this review and what it found.
Cochrane Reviews cover a wide range of interventions to help couples with infertility or subfertility to conceive, and these are updated to take account of new evidence or introduce new review methods. One of the reviews, looking at preconception lifestyle advice for people with infertility, was updated for the first time in April 2021 and we asked lead author, Tessy Boedt from the Department of Chronic Diseases and Metabolism at KU Leuven in Belgium to tell us more.
Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. In May 2021, we published the first version of a living systematic review on the effects of vitamin D supplementation and, in this podcast, Vanessa Piechotta talks to the first author and her colleague at the University Hospital in Cologne Germany, Julia Stroehlein, about the potential effects of vitamin D and the evidence they’ve found.
Some Cochrane reviews investigate the effects of different ways of stopping, rather than starting treatments. A new review in April 2021 does this for adults who have been taking antidepressants for some time. One of the authors, Mieke van Driel from The University of Queensland in Australia tells us more in this podcast.
In March 2021, the Cochrane Neuro-Oncology Group published a series of eight new complex systematic reviews on priority topics for the brain tumour community. These were selected from the most important unanswered questions identified by people in this area using James Lind Alliance Priority Setting Partnership methods, which bring together patients and the public with practitioners. One of the reviews was a network meta-analysis of treatments for glioblastoma in the elderly and we asked lead author, Catherine Hanna from the University of Glasgow in the UK, to tell us about the condition and the review.
Many healthcare organizations use electronic health records to manage patient data and it has been suggested that it may be beneficial if patients can access their own records as well. In this podcast, Christina Cannellopoulos talks with lead author Elske Ammenwerth, a researcher in Medical Informatics from the University UMIT TIROL in Austria, about their Cochrane Review on this topic.
Is plasma from people who have recovered from COVID-19 an effective treatment for people with COVID-19?
Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. We’re keeping these reviews up to date as new evidence emerges and are now on the fourth version of our living review of convalescent plasma and hyperimmune immunoglobulin for COVID-19 patients, which was published in May 2021. In this podcast, Vanessa Piechotta speaks with one of the lead authors, Claire Iannizzi both from the University Hospital Cologne in Germany about the latest findings.
Postnatal depression affects many women in the months after having their baby and one of the early Cochrane Reviews looked at its treatment with antidepressants. The very first version of the review was published in 2001, and the review has been refreshed and updated again, with a new version published in February 2021. Here’s one of the authors, Claire Wilson from King’s College London in the UK, to tell us more.
Infectious diarrhoea is responsible for many thousands of deaths every day around the world and probiotics have been suggested as a possible treatment. The relevant Cochrane Review was updated for the second time in December 2020 and first author, Shelui Collinson from the Liverpool School of Tropical Medicine in the UK describes the latest findings in this podcast.